An observational study in Infertility, sponsored by Reproductive Medicine Associates of New Jersey. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-03.
Sponsored by Reproductive Medicine Associates of New Jersey · Observational
Use of discarded embryos to advance laboratory expertise and technology in the area of human embryo development and assisted reproductive technologies
1- Testing methods or freezing before implementing techniques. 2- Develop cell surgery and micromanipulation techniques. 3- Develop methods to optimize the determinations of genes and chromosomes 4- Quality-assess laboratory equipment. 5- Test proficiency of laboratory staff. 6- Analyze what effects the early development of embryos. 7- Develop new methods and media to allow for higher survival rates of embryos. 8- Develop non-invasive tests for predicting embryo quality to predict IVF success.
2,085 studies on the registry are indexed under Infertility; 357 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 200 across 592 observational studies indexed under Infertility.
Browse Infertility studies →Reproductive Medicine Associates of New Jersey is the lead sponsor of 55 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients undergoing infertility treatment
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
none
Exclusion Criteria:
none
Methods for freezing -embryos
To test, standardize and implement better methods for the freezing embryos prior to these techniques being used in the clinical setting
Time frame: duration of the study
Development non-invasive tests
To develop non-invasive tests for predicting embryo quality as well as IVF success
Time frame: duration of the study
Factors that control embryo development
To analyze embryos to learn more about what controls their early development and function.
Time frame: duration of the study
The record gives a start of Apr 2003, a primary completion of Dec 2028 and a completion of Dec 2029. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Reproductive Medicine Associates of New Jersey